Advertisement

A Perspective on Cancer Immunology and Immunotherapy

  • Alan N. Houghton

Keywords

Serratia Marcescens Innate Immune Cell Blood Group Antigen Cancer Immunology Unique Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jenner, E., 1801. An inquiry into the causes and effects of the Variolae Vacciniae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow-pox, Third edition, D.N. Shury, London.Google Scholar
  2. 2.
    Coley, W. B., 1893, The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases, Am. J. Med. Sci. 105:487–511.CrossRefGoogle Scholar
  3. 3.
    Hall, S. S., 1997. A Commotion in the Blood. Life, Death and the Immune System, Henry Holt & Co., New York.Google Scholar
  4. 4.
    Gratia, A. and Linz, R., 1931, Le phénoméne de Schwartzman dans le sarcome du Cobaye, CR Séances Soc. Biol. Ses. Fil. 108:427–428.Google Scholar
  5. 5.
    Shear, M. J., Turner, F. C., Perrault, A. and Shovelton, T., 1943, Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate, J. Natl. Cancer Inst. 4:81–97.Google Scholar
  6. 6.
    Shear, M. J., 1944, Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide, J. Natl. Cancer Inst. 4:461–476.Google Scholar
  7. 7.
    Algire, G. H., Legallais, F. Y. and Anderson, B. F., 1952, Vascular reactions of normal and malignant tissues in vivo. V. Role of hypertension in action of bacterial polysaccharide on tumors, J. Nat. Cancer Inst. 12:1279–1295.PubMedGoogle Scholar
  8. 8.
    Nowotny, A., 1969, Molecular aspects of endotoxic reactions, Bacteriol. Rev. 33:72–98.PubMedGoogle Scholar
  9. 9.
    Parr, I., Wheeler, E. and Alexander, P., 1973, Similarities of the antitumor actions of endotoxin, lipid A and double-stranded RNA, Br. J. Cancer. 27:370–389.PubMedGoogle Scholar
  10. 10.
    Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U. S. A. 72:3666–3670.Google Scholar
  11. 11.
    Janeway, C. A., Jr., 1989, Approaching the asymptote? Evolution and revolution in immunology, Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1:1–13.Google Scholar
  12. 12.
    Amos, D. B., 1986, Recollections of Dr. Peter Gorer, Immunogenetics. 24:341–344.PubMedCrossRefGoogle Scholar
  13. 13.
    Ehrlich, P., 1897, Die Wertbestimmung des Diphterieheilserums und deren theoretische Grundlagen, Klinische Jahrbucher. 6:299–326.Google Scholar
  14. 14.
    Ehrlich, P., 1906. Collected Studies on Immunity, John Wiley & Sons, New York.Google Scholar
  15. 15.
    Landsteiner, K., 1901, Ueber Agglutinationserscheinungen normalen menschlichen Blutes, Wein Klin. Wochenschr. 14:1132–1134.Google Scholar
  16. 16.
    von Dungern, E. and Hirszfeld, L., 1911, Ueber gruppenspezifische Strukturen des Blutes III., Zeitschrift für Immunologische Forschung. 8:526–562.Google Scholar
  17. 17.
    Ehrlich, P. and Morgenroth, J., 1901, Ueber haemolysin, Berliner Klin. Wochenschr. 38:569.Google Scholar
  18. 18.
    Ehrlich, P. and Morgenroth, J., 1957. On haemolysins: Third and fifth communications, Pergamon Press, London.Google Scholar
  19. 19.
    Little, C. C., 1914, A possible Mendelian explanation for a type of an inheritance apparently non-Mendelian in nature, Science. 40:904–906.PubMedCrossRefGoogle Scholar
  20. 20.
    Little, C. C., 1941. The genetics of tumor transplantation, Dover, New York.Google Scholar
  21. 21.
    Gorer, P. A., 1937a, Further studies on antigenetic differences in mouse erythrocytes, J. Pathol. Bacteriol. 44:31–36.CrossRefGoogle Scholar
  22. 22.
    Gorer, P. A., 1937b, The genetic and antigenetic basis of tumour transplantation, J. Pathol. Bacteriol. 44:691–697.CrossRefGoogle Scholar
  23. 23.
    Gorer, P. A., 1938, The antigenic basis of tumour transplantation, J. Pathol. Bacteriol. 44:231–252.CrossRefGoogle Scholar
  24. 24.
    Gorer, P. A., 1959, The immunogenetics of cancer, Jaarb. K. Ned. Bot. Ve. 9:90–97.Google Scholar
  25. 25.
    Gorer, P. A., Lyman, S. and Snell, G. D., 1948, Studies on the genetic and antigenic basis of tumor transplantation: linkage between a histocompatibility gene and “fused” in mice, Proc. Royal Soc. London Ser. B. 135:499–505.Google Scholar
  26. 26.
    Robinson, J., Waller, M. J., Parham, P., de Groot, N., Bontrop, R., Kennedy, L. J., Stoehr, P. and Marsh, S. G., 2003, IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex, Nucleic Acids Res. 31:311–314.PubMedCrossRefGoogle Scholar
  27. 27.
    Gross, L., 1950, Susceptibility of suckling-infant, and resistance of adult, mice of the C3H and of the C57 lines to inoculation with AKR leukemia, Cancer. 3:1073–1087.PubMedCrossRefGoogle Scholar
  28. 28.
    Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13:835–837.PubMedGoogle Scholar
  29. 29.
    Prehn, R. T. and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18:769–778.PubMedGoogle Scholar
  30. 30.
    Klein, G., 2001, The strange road to the tumor-specific transplantation antigens (TSTAs), Cancer Immunity. 1:6.PubMedGoogle Scholar
  31. 31.
    Basombrio, M. A., 1970, Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene, Cancer Res. 30:2458–2462.PubMedGoogle Scholar
  32. 32.
    Burnet, F., 1970, The concept of immunological surveillance, Prog. Exp. Tumor Res. 13:1–27.PubMedGoogle Scholar
  33. 33.
    Thomas, L., 1982, On immunosurveillance in human cancer, Yale J. Biol. Med. 55:329–333.PubMedGoogle Scholar
  34. 34.
    Hewitt, H. B., Blake, E. R. and Walder, A. S., 1976, A critique of the evidence for active host defense against cancer, based on personal studies of 27 murine tumours of spontaneous origin, Br. J. Cancer. 33:241–259.PubMedGoogle Scholar
  35. 35.
    Stutman, O., 1974, Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice, Science. 183:534–536.PubMedCrossRefGoogle Scholar
  36. 36.
    Stutman, O., 1975, Immunodepression and malignancy, Adv Cancer Res. 22:261–422.PubMedCrossRefGoogle Scholar
  37. 37.
    Pel, A. V., Vessiere, F. and Boon, T., 1983, Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis, J. Exp. Med. 157:1992–2000.PubMedCrossRefGoogle Scholar
  38. 38.
    Dye, E. S. and North, R. J., 1981, T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases, J. Exp. Med. 154:1033–1042.PubMedCrossRefGoogle Scholar
  39. 39.
    North, R. J., 1982, Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, J. Exp. Med. 155:1063–1074.PubMedCrossRefGoogle Scholar
  40. 40.
    Mills, C. D. and North, R. J., 1983, Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells, J. Exp. Med. 157:1448–1460.PubMedCrossRefGoogle Scholar
  41. 41.
    Bursuker, I. and North, R. J., 1984, Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity, J. Exp. Med. 159:1312–1321.PubMedCrossRefGoogle Scholar
  42. 42.
    North, R. J. and Bursuker, I., 1984, Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells, J. Exp. Mede. 159:1295–1311.CrossRefGoogle Scholar
  43. 43.
    Bursuker, I. and North, R. J., 1985, Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors, Cancer Immunology & Immunotherapy. 19:215–218.Google Scholar
  44. 44.
    Dunn, G. P., Old, L. J. and Schreiber, R. D., 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity. 21:137–148.PubMedCrossRefGoogle Scholar
  45. 45.
    Pukel, C. S., Lloyd, K. O., Travassos, L. R., Dippold, W. G., Oettgen, H. F. and Old, L. J., 1982, GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody, J. Exp. Med. 155:1133–1147.PubMedCrossRefGoogle Scholar
  46. 46.
    De Plaen, E., Lurquin, C., Van Pel, A., Mariame, B., Szikora, J. P., Wolfel, T., Sibille, C., Chomez, P. and Boon, T., 1988, Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation, Proc. Natl. Acad. Sci. U. S. A. 85:2274–2278.PubMedCrossRefGoogle Scholar
  47. 47.
    Vijayasaradhi, S., Bouchard, B. and Houghton, A. N., 1990, The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product, J. Exp. Med. 171:1375–1380.PubMedCrossRefGoogle Scholar
  48. 48.
    van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T., 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science. 254:1643–1647.PubMedCrossRefGoogle Scholar
  49. 49.
    Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J. and Houghton, A. N., 1999, Coupling and uncoupling of tumor immunity and autoimmunity, J. Exp. Med. 190:1717–1722.PubMedCrossRefGoogle Scholar
  50. 50.
    Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. and Kasper, D. L., 2005, An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system, Cell. 122:107–118.PubMedCrossRefGoogle Scholar
  51. 51.
    Houghton, A. N., 1994, Cancer antigens: Immune recognition of self and altered self, J. Exp. Med. 180:1–4.PubMedCrossRefGoogle Scholar
  52. 52.
    Matzinger, P., 1994, Tolerance, danger, and the extended family, Ann. Rev. Immunol. 12:991–1045.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Alan N. Houghton
    • 1
  1. 1.Swim Across America LaboratoryMemorial Sloan-Kettering Cancer CenterNew York

Personalised recommendations